Cargando…
Reducing respiratory syncytial virus (RSV) hospitalization in a lower-income country by vaccinating mothers-to-be and their households
Respiratory syncytial virus is the leading cause of lower respiratory tract infection among infants. RSV is a priority for vaccine development. In this study, we investigate the potential effectiveness of a two-vaccine strategy aimed at mothers-to-be, thereby boosting maternally acquired antibodies...
Autores principales: | Brand, Samuel PC, Munywoki, Patrick, Walumbe, David, Keeling, Matthew J, Nokes, David James |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
eLife Sciences Publications, Ltd
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7556875/ https://www.ncbi.nlm.nih.gov/pubmed/32216871 http://dx.doi.org/10.7554/eLife.47003 |
Ejemplares similares
-
Implications of gestational age at antenatal care attendance on the successful implementation of a maternal respiratory syncytial virus (RSV) vaccine program in coastal Kenya
por: Nyiro, Joyce U., et al.
Publicado: (2020) -
Quantification and determinants of the amount of respiratory syncytial virus (RSV) shed using real time PCR data from a longitudinal household study
por: Wathuo, Miriam, et al.
Publicado: (2017) -
Modeling household dynamics on Respiratory Syncytial Virus (RSV)
por: Mahikul, Wiriya, et al.
Publicado: (2019) -
Model-based estimates of transmission of respiratory syncytial virus within households
por: Kombe, Ivy K., et al.
Publicado: (2019) -
Influence of age, severity of infection, and co-infection on the duration of
respiratory syncytial virus (RSV) shedding
por: MUNYWOKI, P. K., et al.
Publicado: (2015)